Details for New Drug Application (NDA): 091076
✉ Email this page to a colleague
The generic ingredient in DIAZEPAM is diazepam. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for 091076
Tradename: | DIAZEPAM |
Applicant: | Novel Labs Inc |
Ingredient: | diazepam |
Patents: | 0 |
Suppliers and Packaging for NDA: 091076
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIAZEPAM | diazepam | GEL;RECTAL | 091076 | ANDA | Lupin Pharmaceuticals,Inc. | 43386-280 | 43386-280-02 | 1 PACKAGE in 1 CARTON (43386-280-02) / 2 SYRINGE in 1 PACKAGE (43386-280-01) / 2 g in 1 SYRINGE (43386-280-03) |
DIAZEPAM | diazepam | GEL;RECTAL | 091076 | ANDA | Lupin Pharmaceuticals,Inc. | 43386-281 | 43386-281-02 | 1 PACKAGE in 1 CARTON (43386-281-02) / 2 SYRINGE in 1 PACKAGE (43386-281-01) / 4 g in 1 SYRINGE (43386-281-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;RECTAL | Strength | 10MG/2ML (5MG/ML) | ||||
Approval Date: | May 30, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;RECTAL | Strength | 20MG/4ML (5MG/ML) | ||||
Approval Date: | May 30, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription